Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin

被引:233
|
作者
Boutell, JM [1 ]
Thomas, P
Neal, JW
Weston, VJ
Duce, J
Harper, PS
Jones, AL
机构
[1] Univ Wales Coll Med, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales
[2] Univ Wales Coll Med, Dept Histopathol, Cardiff CF4 4XN, S Glam, Wales
基金
英国医学研究理事会;
关键词
D O I
10.1093/hmg/8.9.1647
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We detected an interaction of the N-terminus of huntingtin (htt171) with the C-terminal region of the nuclear receptor co-repressor (N-CoR) using the yeast two-hybrid system. This interaction was repeat length dependent and specific to htt171; the corepressor did not interact with the repeat carrying a section of atrophin 1 nor with the androgen receptor or polyglutamine alone. The interaction was confirmed using His-tagged Escherichia coli-expressed C-terminal human and rat co-repressor protein which pulled full-length huntingtin out of homogenized rat brain and in pull-down assays. The N-CoR represses transcription from sequence-specific ligand-activated receptors such as the retinoid X-thyroid hormone receptor dimers end other nuclear receptors including Mad-Max receptor dimers, The mechanism of this repression appears to be through the formation of a complex of repressor proteins including the N-CoR, mSin3 and histone deacetylases. We have used N-CoR and mSin3A antibodies in immunohistochemical studies and find that in Huntington's disease (HD) cortex and caudate, the cellular localization of these proteins is exclusively cytoplasmic whilst in control brain they are localized in the nucleus as well as the cytoplasm; mSin3A immunoreactivity also occurred in a subset of huntingtin positive intranuclear inclusions. The relocalization of repressor proteins in HD brain may alter transcription and be involved in the pathology of the disease.
引用
收藏
页码:1647 / 1655
页数:9
相关论文
共 50 条
  • [1] The involvement of transcriptional repressor proteins in Huntington's disease
    Jones, L
    Duce, J
    Elliston, L
    Harper, PS
    JOURNAL OF MEDICAL GENETICS, 2001, 38 : S65 - S65
  • [2] Huntington's disease gene product, huntingtin, associates with microtubules in vitro
    Tukamoto, T
    Nukina, N
    Ide, K
    Kanazawa, I
    MOLECULAR BRAIN RESEARCH, 1997, 51 (1-2): : 8 - 14
  • [3] The interaction of transcriptional regulatory proteins with huntingtin: implications for Huntington's disease aetiology.
    Jones, L
    Thomas, P
    Elliston, L
    Harper, PS
    Neal, JW
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A277 - A277
  • [4] Huntingtin-protein interactions and the pathogenesis of Huntington's disease|
    Li, SH
    Li, XJ
    TRENDS IN GENETICS, 2004, 20 (03) : 146 - 154
  • [5] Aberrant splicing of mutant huntingtin in Huntington's disease knock-in pigs
    Tong, Huichun
    Yang, Tianqi
    Liu, Li
    Li, Caijuan
    Sun, Yize
    Jia, Qingqing
    Qin, Yiyang
    Chen, Laiqiang
    Zhao, Xianxian
    Zhou, Gongke
    Yan, Sen
    Li, Xiao-Jiang
    Li, Shihua
    NEUROBIOLOGY OF DISEASE, 2023, 187
  • [6] HUNTINGTON'S DISEASE: UNDERSTANDING THE PATHOPHYSIOLOGY THROUGH THE HUNTINGTIN GENE
    Nasrullah, Md.
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (01): : 534 - 541
  • [7] Characterising the Huntington's disease gene product
    Wood, J
    Macmillan, JC
    Thomas, P
    Lowenstein, PR
    Harper, PS
    Jones, AL
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1995, 23 (04) : S595 - S595
  • [8] Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease
    Rodrigues, Filipe B.
    Byrne, Lauren M.
    Johnson, Eileanoir
    Wijeratne, Peter
    de Vita, Enrico
    Alexander, Daniel
    Palermo, Giuseppe
    Czech, Christian
    Schobel, Scott
    Scahill, Rachael
    Heslegrave, Amanda
    Zetterberg, Henrik
    Wild, Edward
    NEUROLOGY, 2019, 92 (15)
  • [9] Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease
    Byrne, Lauren M.
    Rodrigues, Filipe B.
    Johnson, Eileanor B.
    Wijeratne, Peter A.
    De Vita, Enrico
    Alexander, Daniel C.
    Palermo, Giuseppe
    Czech, Christian
    Schobel, Scott
    Scahill, Rachael I.
    Heslegrave, Amanda
    Zetterberg, Henrik
    Wild, Edward J.
    SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (458)
  • [10] Huntingtin aggregation and toxicity in Huntington's disease
    Bates, G
    LANCET, 2003, 361 (9369): : 1642 - 1644